GlassScriptPhysician profile
Brandy B Fouch
NPI 1417967753
$1,721.23
in general payments reported to CMS, 2019-2025
17 companies · $87.63 in 2025
The $87.63 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $323 · 2021: $292 · 2022: $338 · 2023: $197 · 2024: $176 · 2025: $87.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $339.86 | 2019-2024 | |
| Tris Pharma INC | $225.45 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $216.90 | 2020-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Ironshore Pharmaceuticals INC. | $139.10 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $134.11 | 2019-2022 | |
| Corium, LLC | $119.95 | 2022-2023 | Azstarys |
| Baxter Healthcare | $87.45 | 2022 | |
| Sanofi Pasteur INC. | $87.43 | 2019-2023 | |
| Sobi, INC | $82.73 | 2019-2022 | |
| Glaxosmithkline, LLC. | $62.03 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $61.36 | 2024-2025 | |
| Dermira, INC. | $40.62 | 2020-2021 | |
| Neurelis, INC. | $38.76 | 2021 | |
| Supernus Pharmaceuticals, INC. | $33.54 | 2024 | Qelbree |
| Collegium Pharmaceutical, INC. | $17.56 | 2025 | Jornay Pm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $17.48 | 2025 | Daybue |
| Krystal Biotech INC | $16.90 | 2025 | Vyjuvek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Fouch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.